Medline Industries, a major medical supplier, is now trading on the Nasdaq as MDLN. This IPO raised $6.26 billion, with an initial stock price of $29 that soared to $41 on the first day. The company is valued at about $54 billion but saw a 3.7% dip the following day.

The IPO was the largest in the US for 2025 and the biggest stock debut in four years. Medline raised more than $5 billion, becoming the fifth US firm to do so in the past decade. It sets an optimistic tone for 2026, with potential IPOs from companies like SpaceX and Anthropic.

Medline planned to issue 179 million shares but increased to 216 million due to high demand. They added a 30-day option for underwriters to buy 32.4 million more shares. The company aims to use the proceeds to repay debt, for general purposes, and to cover offering expenses.

With a vast catalog of 190,000 products, 43,000 employees, and next-day delivery for 95% of US customers, Medline surprised investors with its IPO scale. It has 69 global distribution centers, a private fleet of 2000 trucks, and over 50 years of annual sales growth, providing a wide range of health supplies.

The healthcare sector, which is adding the most jobs in the US, is poised for growth. Medline’s IPO success reflects the industry’s potential, with breakthroughs like government-subsidized weight loss and diabetes management medicines on the horizon.

Read more at Yahoo Finance: Medline IPO sets surprising record